ANAB
AnaptysBio Inc (ANAB) Investor Questions
Review AnaptysBio Inc (ANAB) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- AnaptysBio Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 45
- Annual revenue
- $234.60M
- Annual net income
- $-13.23M
- Annual free cash flow
- $19.61M
AnaptysBio Inc (ANAB) Investor Questions research
AnaptysBio Inc trades under the ticker ANAB. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ANAB through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.